Long-term, observational cohort study of adults with plaque psoriasis (PsO), who are new users of deucravacitinib, tumour necrosis factor inhibitor (TNFi) biologics, non-TNFi biologics, or non-biologic therapies in the real-world clinical setting

Data sources

• Data source(s):
  Système National des Données de Santé (French national health system main database)
• Data source(s), other:
  The Danish Registries; The Norwegian National Registries; The Finnish National Registries; The German Registry on the Treatment of Psoriasis with Biologics and Systemics (PsoBest); The Spanish Registry of Systemic Treatments in Psoriasis (BIOBADADERM)
• Data sources (types):
  Disease registry

  Other
• Data sources (types), other:
  National Health Registry/Data System

Use of a Common Data Model (CDM)

• CDM mapping:
  Yes

Data quality specifications

• Check conformance:
  Yes
• Check completeness:
  Yes
• Check stability:
  Unknown
• Check logical consistency:
  Yes

Data characterisation

• Data characterisation conducted:
  Yes
• Data characterisation moment:
  after extract-transform-load to a common data model